CZ66492A3 - Preparation for inhibiting yeast candida albicans to mucosal epithelium - Google Patents

Preparation for inhibiting yeast candida albicans to mucosal epithelium Download PDF

Info

Publication number
CZ66492A3
CZ66492A3 CS92664A CS66492A CZ66492A3 CZ 66492 A3 CZ66492 A3 CZ 66492A3 CS 92664 A CS92664 A CS 92664A CS 66492 A CS66492 A CS 66492A CZ 66492 A3 CZ66492 A3 CZ 66492A3
Authority
CZ
Czechia
Prior art keywords
chitin
preparation
albicans
yeast
candida albicans
Prior art date
Application number
CS92664A
Other languages
Czech (cs)
Inventor
Dagmar Rndr Drsc Vrana
Alena Prof Mudr Drsc Tomsikova
Adolf Mudr Kocna
Original Assignee
Mikrobiologicky Ustav Avcr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mikrobiologicky Ustav Avcr filed Critical Mikrobiologicky Ustav Avcr
Priority to CS92664A priority Critical patent/CZ278840B6/en
Publication of CZ66492A3 publication Critical patent/CZ66492A3/en
Publication of CZ278840B6 publication Critical patent/CZ278840B6/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

A preparation for inhibiting Candida albicans yeast adherence to mucosal epithelium containing, as an active ingredient, a chitin-glucan complex, isolated from the cell wall of the mycelium Aspergillus niger. The preparation inhibits the virulence of yeast and can be used for treatment and prophylaxis of vaginal colpitis. The preparation according to the invention uses part of waste Aspergillus niger mycelia from production of citric acid and therefore contributes to the solution of ecological problems.

Description

Vynález se týká prostředku k inhibici adherence kvasinky Candida albicans na slizniční epitel. Prostředek obsahuje účinnou složku izolovanou z mycelia při výrobě kyseliny citrónové.The invention relates to a composition for inhibiting the adherence of yeast Candida albicans to mucosal epithelium. The composition comprises an active ingredient isolated from mycelium in the manufacture of citric acid.

Dosavadní _s.tav technikyBACKGROUND OF THE INVENTION

Je známou skutečností, Se z vaginálních kolpitid je mykotická infekce tou nejčastější, nejčastěji vede k recidivám a je nejčastějším důvodem k návštěvě lékaře. Trvalé recidivy vedou navíc ke vzniku somatopsychických a psychosomatických poruch u pacientek. Invasivita patogenních kvasinek je podmíněna jejich schopností adherovat na buněčné stěny slizničních epitelií, která je realisována chemickou reakcí mezi komponentami buněčných stěn kvasinky a epitelie. Vznik této vazby je patrně molekulárně biologickým signálem pro změnu způsobu růstu kvasinky z ovoidní na vláknitou formu, která snadno proniká do hlubších vrstev napadeného orgánu (Krogh, Holmstrup, Vedtofte a Pindborg ; A the yeast flora in human oral leukoplakia. ΙΧ*·ΐ> Spec. Symp, Yeasts Yeasts in study of Internát. Smolenice iss:It is a known fact that Se out of vaginal colpitis is the most common fungal infection, most often leads to relapses and is the most common reason to visit a doctor. In addition, persistent relapses lead to somatopsychic and psychosomatic disorders in patients. Invasiveness of pathogenic yeasts is conditioned by their ability to adhere to the cell walls of the mucosal epithelium, which is realized by a chemical reaction between the cell wall components of yeast and epithelium. The formation of this bond appears to be a molecular biological signal for changing the yeast's growth pattern from ovoid to filamentous form, which easily penetrates into the deeper layers of the infected organ (Krogh, Holmstrup, Vedtofte and Pindborg; Special Symp, Yeasts Yeasts in study of Dormitory Smolenice iss:

Human Environment, Abstr. str. 62.). Adherenci kvasinek na lidské epitelie lze inhibovat např. aminocukry (Segal, Lehrer a Ofek.Human Environment, Abstr. 62.). Yeast adherence to human epitheliums can be inhibited by, for example, amino sugars (Segal, Lehrer and Ofek).

Adherence o f C a n di d<Adherence o f C and n di d <

a 1bicans h u in a n v a g i n a 1 e p i t helia 1 cellssInhibition by amino sugars. Exp. Cell Biol. 50, 13.a 1bicans h u in a n v a g i n e a p helium 1 cellssInhibition by amino sugars. Exp. Cell Biol. 50, 13.

Podstata vvnáleThe essence of the invention

Novy prostředek k inhibici adherence kvasinek např, Candida albicans na slizniční epitel vyznačený tím, u· b ct h LI j ® J cl k OA novel means for inhibiting yeast adherence, e.g., Candida albicans to mucosal epithelium characterized by:

-i c i n i i o ia 551 o ž k li c h i t i η ~· g .1 li k a n o v ý k o *τι p 1 e χ buněčných stfén mycsl i a-i c i n i i ia 551 l c h i t i η ~ · g .1 li c a n o l o o * τι p 1 e χ mycsl i cell wall

Aspergillus niger. Prostředek využívá schopnosti chitinu (N--acety 1 -glukosaminu) inhibovat adherenci patogenních kvasinek na epitelie lidských sliznic, čímž snižuje jajich virulenci. Získává se z buněčné stěny plísní , která obsahuje velké množství chitinu, tedy polymeru N-acety1-D-glukosaminu s β-1-4 vazbami (Peberdy J.F.s Fungal cell walls. In:Biochemistry of cell wall and membrane in Fungi. Springer Verlag 1990, P.J.Kuhn, A.P.J. Třinci, M.S. Yu.ng, M.W. Goosey, Eds.). Vzniká jako odpadni produkt při výrobě kyseliny citrónové pro potravinářské či farmaceutické potřeby, kdy odpadá, velké množství mycelia produkční plísně Aspergillus niger, které je obtížným odpadem.Aspergillus niger. The composition utilizes the ability of chitin (N-acetyl-glucosamine) to inhibit the adherence of pathogenic yeasts to human mucosal epithelium, thereby reducing their virulence. It is obtained from a fungal cell wall that contains a large amount of chitin, a polymer of N-acetyl-D-glucosamine with β-1-4 bonds (Peberdy JFs Fungal cell walls. , PJ Kuhn, APJ Trinec, MS Yu.ng, MW Goosey, Eds.). It is produced as a waste product in the production of citric acid for food or pharmaceutical needs, when a large amount of mycelium producing mold Aspergillus niger, which is a difficult waste, is eliminated.

Chitin-glukanový komplex z mycelia provozního kmene Asp. niger z výroby kyseliny citrónové v závodě Lachema Kaznějov byl získán alkalickou hydrolysou 1 kg mokrého mycelia v 11 ÍN KOH, při teplotě 100°C po dobu i hodiny, čímž byla odstraněna cytoplasma buněk i proteinová složka buněčné stěny. Pevný zbytek byl promýván do neutrální reakce a lyofi 1isován. Látka dává charakteristické IČ spektrum pro glukan 920, 891 a 774 a pro chitin 1618, 1379 a 781.Chitin-glucan complex from the mycelium of the Asp strain. niger from citric acid production in the Lachema Kaznějov plant was obtained by alkaline hydrolysis of 1 kg wet mycelium in 11 N KOH at 100 ° C for 1 hour, thereby removing both cell cytoplasm and the cell wall protein component. The solid residue was washed until neutral and lyophilized. The substance gives a characteristic IR spectrum for glucan 920, 891 and 774 and for chitin 1618, 1379 and 781.

Získaný produkt byl v pokuse in vitro testován na schopnost inhibovat adherenci virulentního kmene C. albicans (isolovaného v gynekologické sliznice a v ambulanci) pokusu in na buňky vivo na experimentální kandidosy u králičíchThe product obtained was tested in an in vitro experiment for the ability to inhibit the adherence of a virulent C. albicans strain (isolated in the gynecological mucosa and ambulance) in an in vivo cell to experimental candidiasis in rabbits

Příklady provedeni vynálezuDETAILED DESCRIPTION OF THE INVENTION

Přiklad 1 lidské vaginální a bukálníExample 1 human vaginal and buccal

Stanoveni schopnosti chitin-glukanového komplexu inhibovat adherenční aktivitu Candida. albicans- na buňky vaginální a bukální sliznice in vitro.Determination of the ability of the chitin-glucan complex to inhibit Candida adherence activity. albicans - cells of the vaginal and buccal mucosa in vitro.

Pokus proběhl ve 4 variantách:The experiment was carried out in 4 variants:

var. 1 : epitelie + c. albicans + chitin-glukan (vlastni pokus) var.2 : epitelie + C. albicans + formalin (mrtvé kvasinky) v a r. 3 : e p i t e 1 i e + C. a 1 b i c a n s + 5 pe c . a 11t1 set u. m ( i n a k t i v o v a n é kvas inky) var.4 : epitelie + C. albicans + pufr (živé kvasinky)var. 1: epithelium + c. Albicans + chitin-glucan (own experiment) var.2: epithelium + C. albicans + formalin (dead yeast) v a r. a 11t1 set u. m (yeast yeast) var.4: epithelium + C. albicans + buffer (live yeast)

Varianty 2,3 a 4 byly trojnásobnou, kontrolou,Variants 2,3 and 4 were triple,

Provedení pokusu:To perform the experiment:

suspense A: 25 mg chitin-g 1 ukanu. /1 ml fosf. pufru, pH = 7 suspense B; C, albicans, 24 hod. stará, vyrostlá na Sabouraudově agaru, suspendovaná ve fosf. pufru pH = 7, na hustotu 5 podle Nc Farlanda (Tomšíkova A., Sandula J.: Imunologie a patogenita. V: Kvasinky ve výzkumu a praxi. Academia 1786, D. Vraná, Eds., str. 265.) suspense Csbukální či vaginální slizniční epitelie získané stěrem do fost. pufru pH = 7, 3x promyté tímtéž pufrem a konečně do i ml téhož pufru. resuspendované.suspension A: 25 mg chitin-g 1 ukan. / 1 ml phosph. buffer, pH = 7 suspension B; C, albicans, 24 h, grown on Sabouraud agar, suspended in phosph. buffer pH = 7, to density 5 according to Nc Farland (Tomšíkova A., Sandula J .: Immunology and pathogenicity. V: Yeast in research and practice. Academia 1786, D. Vraná, Eds., p. 265.) vaginal mucosal epithelium obtained by smear into fost. buffer pH = 7, washed 3 times with the same buffer and finally into 1 ml of the same buffer. resuspended.

i ml suspense A + 1 ml suspense B se smíchají a inkubují 24 hod. pči 4 °C. Poté se 0.2 ml spojených suspensí (A + B) smísí s 0.2 ml promytých epitelií (suspense C) a inkubuje se za stálého tčepání 90 min. Následuje filtrace pčes membránový filtr Synpor 1 a promytí sedimentu na filtru 100 ml fosf. pufru pH = 7. Zhotoví se otiskový preparát na podložní sklo, po zaschnutí a. fixaci plamenem se barví postupem podle Grama a mikroskopicky se hodnotí počet G+ kvasinek, dotýkajících se nebo ležících na G~ epiteliích nepravidelného tvaru.1 ml of suspension A + 1 ml of suspension B are mixed and incubated for 24 hours at 4 ° C. Then 0.2 ml of the combined suspensions (A + B) are mixed with 0.2 ml of washed epitheliums (suspension C) and incubated with shaking for 90 min. Filtration through a Synpor 1 membrane filter followed by washing the sediment on a 100 ml phosphor filter. buffer pH = 7. The impression glass is prepared, after drying and flame fixation, stained by the Gram procedure and the number of G + yeasts touching or lying on irregularly shaped G-epitheliums is microscopically evaluated.

V kontrolních variantách byl pro pčípravu suspense B použit místo fosfátového pufru 0,9 X formalin (varianta 2) nebo specifické králičí antiserum (varianta 3). Mikroskopicky bylo hodnoceno 100 epitelií viz tabulka I.In the control variants, 0.9X formalin (variant 2) or a specific rabbit antiserum (variant 3) was used instead of phosphate buffer to prepare suspension B. 100 epitheliums were evaluated microscopically, see Table I.

Tab. ITab. AND

epi telie epi telie počet b b C. albicans na 1 C. albicans at 1 epitelii epithelium var. 1 var. 1 var. 2 var. 2 var. var. 3 3 v ar. 4 v ar. 4 vagináln í vaginal 1,18 1.18 2, 99 2, 99 3,74 3.74 21,07 21.07 bukální buccal 2,70 2.70 4,90 4.90 6,20 6.20 16,40 16.40

Vyhodnocení“. 1. Různý počet buněk C. albicans na 1 epitelii v kontrolním pokuse (varianta 4) byl 20 násobkem počtu buněk v experimentu (varianta 1).Evaluation ". 1. The different number of C. Albicans cells per epithelium in the control (variant 4) was 20 times the number of cells in the experiment (variant 1).

2. Buňky virulentní C. albicans adherují ve větěí míče na buňky vaginálního než bukálního epitelu.2. Virulent C. albicans cells adhere to the vaginal rather than buccal epithelium in the ball.

3. Chitin-glukanový komplex z mycelia Aspergillus niger inhibuje adherenci C. albicans na buňky vaginálního epitelu více než na buňky epitelu bu k á 1 η í ho.3. The chitin-glucan complex of Aspergillus niger mycelium inhibits C. albicans adherence to cells of the vaginal epithelium more than to cells of either epithelial cell.

Příklad 2Example 2

Stanovení schopnosti chitin-glukanového komplexu inhibovat adherenční aktivitu různých kmenů Candida albicans, isolovaných v gynekologické ambulanci , in vitro.Determination of the ability of a chitin-glucan complex to inhibit the adherence activity of various Candida albicans strains isolated in a gynecological outpatient clinic in vitro.

Stejný pokus byl proveden se 4 kmeny C. albicans , isolovanými od 4 pacientek. U těchto kmenů byla předem v k u11 i v ač η ích n ádo bá c h na Sa bou r a ud ov ě teku tém mediu sta noven a specifická rychlost růstu jj a doba zdvojení buněčné hmoty g, aby mohl být posouzen vztah mezi rychlostí růstu a schopností a d h e r e n c e, R ů s t b y 1 s t a n o v e n p o d 1 e o p t i c k é cl e n s i t y k u 11 u t~ y v časovém intervalu 0—24 hod. Výpočet hodnoty jj byl proveden podle rovnice j.> — X./ t . 1/X. Hodnota g byla stan o van a podle vzorce g — 0.69/ jj (Beran a ost. : Růst a množení buněk. V: Kvasinky ve vý z k umu a pra .i.. Ac a clem .i a 1986, Ei. V raná ·, Ed. , str. 169.)» Výsledky udávají tabulky II a III.The same experiment was performed with 4 C. albicans strains isolated from 4 patients. For these strains, the specific growth rate jj and the doubling time of the cell mass g were predetermined in Saudi ra, and the specific growth rate, j, and the doubling time of the cell mass g, in order to assess the relationship between growth rate and ability adherence, Growth 1 determined under 1 eoptical cleat 11 at a time interval of 0-24 hours. The value of jj was calculated according to the equation j.> - X. / t. 1 / X. The value of g was determined to be van and according to the formula g - 0.69 / jj (Aries et al.: Cell growth and multiplication. V: Yeast in research and practice. Ac and clem .ia 1986, Ei. , Ed., P. 169.) »The results are given in Tables II and III.

Tab. IITab. II

kmen strain % nárůst za 24 hod. % increase in 24 hours i-1 i- 1 g/hod g / hour 16 / v a g. / 16 (v a g.) 4,76 4.76 0,002 0,002 345,0 345.0 17/vag./ 17 (vag.) 1825,82 1825,82 0, 120 0, 120 cr -rer Λ , / ·._» cr -rer /, / · ._ » 18/vag./ 18 / vag / 13/ζΤζ, 33 13 / ζΤζ, 33 0, 100 0, 100 6,90 6.90 19/vag./ 19 / vag / 1196,62 1196,62 0, 106 0, 106 6,50 6.50

Kmeny C. albicans od různých dárkyň se liší výrazně svými růstovými charakteristikami. Test schopnosti adherence a inhibičního účinku chitin-glukanu byl uspořádán stejně jako v tab. I.The strains of C. albicans differ significantly from different donor plants in their growth characteristics. The test of adherence and inhibitory effect of chitin-glucan was arranged as in Tab. AND.

Tab. IIITab. III

Kmen Strain počet number b. C Bc albicans na albicans na 1 epitelii 1 epithelium var. var. 1 1 var. 2 var. 2 var. 3 var. 3 var. 4 var. 4 16 16 1,54 1.54 1,66 1.66 2,0 2,0 11,96 11.96 17 17 0,84 0.84 2,68 2.68 22, 56 22, 56 13 13 1,44 1.44 3,96 3.96 1,9 1.9 20, Só 20, So 19 19 Dec 1 , 18 1, 18 1,66 1.66 0, 86 0, 86 4 cr ne 1 J , 7 U 4 cr no 1 J, 7 U

Buňky pomalu rostoucího kmene (kmen 16) měly nižší adherenční schopnost nes buňky rychle rostoucích kmenů. Inhibiční účinek chitin-glukanu je u pomalu rostoucích buněk méně výrazný.The cells of the slowly growing strain (strain 16) had a lower adherence ability to the cells of the rapidly growing strains. The inhibitory effect of chitin-glucan is less pronounced in slow-growing cells.

PříkladExample

Stanovení schopnosti chitin-glukanového komplexu zabránit vzniku experimentální vaginální kandidosy u králičích samic.Determination of the ability of the chitin-glucan complex to prevent experimental vaginal candidiasis in rabbit females.

Schopnost chi tin-g luk. áriového komplexu zabránit vzniku experimentální kandidosy byla testována na králičích samicích, jimž byl do vaginy aplikován chitin-glukan spolu, s virulentní C. albicans.The ability of chi tin-g bow. The ararium complex to prevent experimental candidiasis was tested in female rabbits injected with chitin-glucan into the vagina together with virulent C. albicans.

K pokusu bylo použito 21 králíků. Z virulentního kmene C. albicans byla připravena suspenze v destilované vodé podle McFarlandovy stupnice č. 10 a smísena s chitin-glukanem v poméru í i 1 (navážka chitin-glukanu 25 mg/i ml fyziologického roztoku). 7 králíkům byla aplikována tato suspenze hluboko do pochvy Ix denné po dobu 7 dnů (skup. A). Dalších 7 králíků bylo infikováno samotnými C.albicans ve stejném časovém schématu (skup.B) a konečně posledním 7 experimentálním zvířatům byl stejným způsobem podáván pouze chitin-glukan (skup. C).21 rabbits were used. A suspension was prepared from virulent C. albicans strain in distilled water according to McFarland scale # 10 and mixed with chitin-glucan at a ratio of 1 (chitin-glucan weighed 25 mg / ml saline). 7 rabbits were injected deep into the vagina once daily for 7 days (Group A). A further 7 rabbits were infected with C.albicans alone on the same schedule (group B) and finally the last 7 experimental animals were treated with chitin-glucan only (group C) in the same manner.

Po 7 dnech byly provedeny všem zvířatům výtěry z pochvy, které byly kultivovány 7 dnů na Sabouraudově mediu, s glukózou (kontrolní výtěr byl u všech samic proveden před zahájením pokusu). Současně byly u všech zvířat provedeny kožní testy s mananproteinem C. albicans.After 7 days all vaginal swabs were cultured on Sabouraud's medium for 7 days with glucose (control swab was performed in all females prior to the start of the experiment). At the same time, skin tests were performed on all animals with C. albicans mananprotein.

V kontrolní skupině (skup. B) byl mykologický nález u všech zvířat positivní a samice trpěly výtokem. 7 pokusné skupině, v níž byl zvířatům spolu s infekčním agens současně podán chitin-glukan (skup. A), i v poslední skupině, kde byla zvířata ošetřena pouze chitin—glukanem (skup. C), byl mykologický nález negativní u všech samic. Kožní testy byly negativní u všech 21 zvířat, zařazených v pokuse.In the control group (Group B), the mycological finding was positive in all animals and the females suffered from discharge. In the experimental group in which the animals were co-administered with the infectious agent chitin-glucan (group A), even in the last group where the animals were treated only with chitin-glucan (group C), the mycological finding was negative in all females. Skin tests were negative in all 21 animals enrolled in the experiment.

Průmyslová využitelnostIndustrial applicability

Prostředek podle vynálezu by mohl poskytovat nástroj pro kombinovanou terapii a profylaxi vaginálních my kos.The composition of the invention could provide a tool for the combined therapy and prophylaxis of vaginal mice.

IJ možř<uje li kvi dovat část odpadni ho m y t_ e 1 i aIf it is possible to detect part of the waste m e t i e

Π i r z výroby kyseliny citrónové a přispívá tím k řešení eko problémů. Zavedení preparátu do léčebné praxe by f i n a nční úspo ry n a ná ku p an t i myko t i k v zahraničí.Π i r from citric acid production and thus contributes to solving eco problems. The introduction of the preparation into the medical practice would be a financial saving of the myocardia abroad.

o g i c k ý c ho g i c k ý c h

Claims (1)

Prostředek k .inhibici adherence kvasinek např. Candida albicans na slizniční epitel vyznačený tím, že obsahuje jako účinnou složku chitin-glukanový komplex z buněčných stěn myčelia Aspergillus niger.A composition for inhibiting yeast adherence, e.g., Candida albicans, to the mucosal epithelium, characterized in that it contains as an active ingredient a chitin-glucan complex from Aspergillus niger cell wall cells.
CS92664A 1992-03-05 1992-03-05 Preparation for inhibiting yeast candida albicans adherence to mucosal epithelium CZ278840B6 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS92664A CZ278840B6 (en) 1992-03-05 1992-03-05 Preparation for inhibiting yeast candida albicans adherence to mucosal epithelium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS92664A CZ278840B6 (en) 1992-03-05 1992-03-05 Preparation for inhibiting yeast candida albicans adherence to mucosal epithelium

Publications (2)

Publication Number Publication Date
CZ66492A3 true CZ66492A3 (en) 1994-04-13
CZ278840B6 CZ278840B6 (en) 1994-07-13

Family

ID=5339187

Family Applications (1)

Application Number Title Priority Date Filing Date
CS92664A CZ278840B6 (en) 1992-03-05 1992-03-05 Preparation for inhibiting yeast candida albicans adherence to mucosal epithelium

Country Status (1)

Country Link
CZ (1) CZ278840B6 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2900054A1 (en) * 2006-04-21 2007-10-26 Kitozyme Sa USE OF POLYSACCHARIDES OF FUNGAL ORIGIN AS A PHARMACEUTICAL COMPOSITION OR FOOD SUPPLEMENT FOR HUMAN AND ANIMAL HEALTH

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2900054A1 (en) * 2006-04-21 2007-10-26 Kitozyme Sa USE OF POLYSACCHARIDES OF FUNGAL ORIGIN AS A PHARMACEUTICAL COMPOSITION OR FOOD SUPPLEMENT FOR HUMAN AND ANIMAL HEALTH
WO2007122187A3 (en) * 2006-04-21 2007-12-21 Kitozyme Sa Use of fungal polysaccharides as pharmaceutical composition or food complements
EP2010200B1 (en) * 2006-04-21 2017-07-05 Kitozyme S.A. Use of fungal polysaccharides as pharmaceutical composition or food complements

Also Published As

Publication number Publication date
CZ278840B6 (en) 1994-07-13

Similar Documents

Publication Publication Date Title
CN111727048B (en) Use of isolated rhodococcus erythropolis cell wall skeleton in preparing medicament for treating herpes simplex and/or herpes zoster
CN103316033B (en) Gel and use thereof
EP0721457B1 (en) 2&#39;,5&#39;-OLIGOADENYLATE-2&#39;,3&#39;-CYCLOPHOSPHATES and 2&#39;,5&#39;-OLIGOADENYLATES with antipapilloma virus activity
US12064458B2 (en) Use of Rhodococcus ruber product in treating thermal injury
CN111419829B (en) Application of honokiol in inhibiting streptococcus suis or biofilm thereof
CZ66492A3 (en) Preparation for inhibiting yeast candida albicans to mucosal epithelium
CN115400142B (en) Application of beta-1, 3/alpha-1, 3-glucan in preparation of skin micro-ecological regulating product
KNIGHT Human models for in vivo and in vitro assessment of topical antifungal compounds
Perl et al. Vaginal candidiasis: new method of diagnosis and treatment
Ishchuk et al. The use of polyhydroxylated carboxylic acids and lactones to diminish biofilm formation of the pathogenic yeast Candida albicans
CN101410409A (en) Immunomodulating composition
KR100646593B1 (en) Composition comprising the extract of phellinus mushroom and lactic acid for protecting and treating vaginal viral diseases and uterine cancer
CN1214798C (en) Noka ointment for treating herpes simplex and herpes zoster
KR100461960B1 (en) Application and production of muco-polysaccharide by submerged culture of novel Grifola frondosa HB0071 KCTC 10337BP
CN104306477B (en) Coptis water extract and monomer are preparing the purposes in suppressing Streptococcus suis or intervening streptococcus suis biofilm medicine
CN117137945B (en) Application of ferrous ions in preparation of medicines for inhibiting or treating infection or disease caused by candida albicans
CN1118281C (en) Application of seeweed polyose sulphate
CN110638688A (en) Preparation method and application of artemisinin-loaded lentinus edodes polysaccharide compound
CN114010790B (en) Use of fluorescent whitening agents against fungal infections
CN109758551B (en) A Chinese medicinal composition for treating tinea pedis and vulvovaginal candidiasis
CN112022800B (en) Composition, vaginal gel prepared from composition and application of vaginal gel in resisting human papilloma virus
Singh et al. White leaf disease of Cynodon dactylon Pers., a mycoplasmal disease in India
He et al. Toxicity Evaluation of Honghe Fujie lotion Against Candida Albicans in Vitro and in Vivo
Weber et al. Antifungal therapy of dermatophytosis in guinea pigs and congenitally athymic rats
CN114767708A (en) Stable gynecological bacteriostatic composition and gynecological care solution

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MM4A Patent lapsed due to non-payment of fee

Effective date: 20000305